NCT06450964

Brief Summary

The goal of this observational study is to provide a reference for clinicians to conduct genetic counseling and carry out preimplantation genetic testing of mitochondrial patients. The main questions it aims to answer are:

  • The relationship between mitochondrial mutation load and clinical symptom
  • The symptomatic threshold of common mitochondrial DNA mutations
  • The distribution of mitochondrial mutation load in offspring and genetic rule of mitochondrial DNA mutation
  • The minimum number of eggs taken by preimplantation genetic testing in mitochondrial mutation carriers Biological samples such as blood, urine, oral epithelial cells, nails, some granulosa cells, trophoderm cells, embryo culture fluid, embryo biopsy fluid, and embryo trophoblast cells of the participants will be collected and the mutation loads of them will be measured. The clinical symptoms and mutation load of the participants will be followed up once a year.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
18mo left

Started Sep 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Sep 2024Dec 2027

First Submitted

Initial submission to the registry

June 3, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 10, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

October 28, 2024

Status Verified

June 1, 2024

Enrollment Period

2 years

First QC Date

June 3, 2024

Last Update Submit

October 25, 2024

Conditions

Keywords

mitochondrial diseasesmitochondrial DNA mutationreproductive cohortgenetic counseling

Outcome Measures

Primary Outcomes (1)

  • Symptoms of mitochondrial disease

    The enrolled patients were followed up once a year. Symptoms that the patient has due to mitochondrial DNA mutations are recorded.

    3 years

Secondary Outcomes (2)

  • level of mitochondrial DNA mutation

    3 years

  • Tissue-specific distribution of mitochondrial DNA mutation levels

    When they enrolled

Interventions

Biological samples such as blood, urine, oral epithelial cells and nails of carriers were collected, and some granulosa cells, trophoderm cells, embryo culture fluid, embryo biopsy fluid, and embryo trophoblast cells were collected. Placenta and umbilical cord blood samples of some fetuses were collected after delivery, and the mitochondrial DNA mutation heterogeneity level was determined.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

mtDNA mutation carriers from The First Affiliated Hospital of Anhui Medical University

You may qualify if:

  • Clinical diagnosis of mitochondrial DNA diseases

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Affiliated Hospital of Anhui Medical University

Hefei, Anhui, 230022, China

Location

Biospecimen

Retention: SAMPLES WITH DNA

blood, urine, oral epithelial cells, fingernail, trophectoderm cells, embryo culture medium, amniotic fluid, placenta, granulosa cell

MeSH Terms

Conditions

Mitochondrial Diseases

Interventions

Blood Specimen CollectionUrination

Condition Hierarchy (Ancestors)

Metabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative TechniquesUrinary Tract Physiological PhenomenaReproductive and Urinary Physiological Phenomena

Study Officials

  • Dongmei Ji, Dr.

    The First Affiliated Hospital of Anhui Medical University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 3, 2024

First Posted

June 10, 2024

Study Start

September 1, 2024

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 31, 2027

Last Updated

October 28, 2024

Record last verified: 2024-06

Locations